Disrupting the MAD2L2-Rev1 Complex Enhances Cell Death upon DNA Damage
DNA-damaging chemotherapy agents such as cisplatin have been the first line of treatment for cancer for decades. While chemotherapy can be very effective, its long-term success is often reduced by intrinsic and acquired drug resistance, accompanied by chemotherapy-resistant secondary malignancies. A...
Main Authors: | Nomi Pernicone, Maria Elias, Itay Onn, Dror Tobi, Tamar Listovsky |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2022-01-01
|
Series: | Molecules |
Subjects: | |
Online Access: | https://www.mdpi.com/1420-3049/27/3/636 |
Similar Items
-
Distinct responses to reduplicated chromosomes require distinct Mad2 responses
by: Benjamin M Stormo, et al.
Published: (2016-05-01) -
Maternal genetic polymorphisms in the major mitotic checkpoint genes MAD1L1 and MAD2L1 associated with the risk of survival in abnormal chromosomal fetuses
by: Ying Chan, et al.
Published: (2023-03-01) -
Bridging Gaps in HDR Improvement: The Role of MAD2L2, SCAI, and SCR7
by: Arina A. Anuchina, et al.
Published: (2023-04-01) -
Closing the Mad2 cycle
by: Andrea Musacchio
Published: (2015-05-01) -
Madness and sanity at the time of Indian independence
by: Sanjeev Jain, et al.
Published: (2016-01-01)